扫描式葡萄糖监测系统在糖尿病患者血糖管理中的可用性与安全性

Availability and safety of flash glucose monitoring system in blood glucose management of diabetes patients

目的探讨扫描式葡萄糖监测系统(FGMS)在接受胰岛素治疗的糖尿病患者中的可用性、安全性及满意度。方法选择2021年10月—2022年5月某三级甲等医院118例接受胰岛素治疗的糖尿病患者为研究对象,采用自身对照研究,在晨起空腹、三餐后2 h同时测量患者自我血糖检测(SMBG)和FGMS值,记录与传感器相关不良事件,比较两种血糖监测方式数值一致性和患者满意度。结果2046对SMBG-FGMS数值中符合ISO标准的FGMS数值所占百分比较高(分别为94.7%,95.3%),SMBG与FGMS呈强正相关(r=0.887,P<0.001),与SMBG相比,FGMS能有效识别潜在低血糖且疼痛程度评分低,患者治疗满意度评分较高(均P<0.05)。结论FGMS在接受胰岛素治疗的糖尿病患者中应用安全、可行,可辅助SMBG进行临床决策。

Objective To explore the availability,safety and satisfaction of flash glucose monitoring system(FGMS)in diabetes patients receiving insulin treatment.Methods To select 118 patients with diabetes who received insulin treatment in a tertiary first-class hospital from October 2021 to May 2022 as the study subjects.A self controlled study was conducted to measure the self monitoring of blood glucose(SMBG)and FGMS values of patients on an empty stomach in the morning and 2 hours after three meals,record adverse events related to sensors,and compare the consistency of the two blood glucose monitoring methods and patient satisfaction.Results Among the 2046 pairs of SMBG-FGMS values,the percentage of FGMS values that met ISO standards was relatively high(94.7%and 95.3%,respectively).SMBG and FGMS showed a strong positive correlation(r=0.887,P<0.001).Compared with SMBG,FGMS was able to effectively identify potential hypoglycemia and had a low pain score,with a higher patient satisfaction score(all P<0.05).Conclusion FGMS was safe and feasible in diabetes patients receiving insulin treatment,and can assist SMBG in clinical decision-making.